Region Oestergoetland — Sponsor Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

8 Recruiting

1 Completed trials

4 Countries active

17 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 4 Phase II: 3 Phase IV: 5

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Acute kidney injury 1 Renal cancer 1 Congenital ureteric anomaly 1 Benign renal neoplasm 1 Benign neoplasm of ureter 1

Top IMPs

LEBRIKIZUMAB 1

All trials

12 total

GLUTAMICS III Pending

2024-513575-40-01 Phase III 1 country
A randomised, prospective phase II study of pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in a shortene… Pending

2024-518772-32-00 Phase II 1 country
An interventional, Open-label Study to Evaluate the effect of lebrikizumab on eczema and Skin Barrier Function parameters in lesional and no… Pending

2024-519811-32-00 Phase IV 1 country LEBRIKIZUMAB
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl… Recruiting

2023-506998-35-00 Phase III 4 countries
Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (… Recruiting

2023-508398-10-00 Phase IV 1 country
Can estimated glomerular filtration rate (eGFR) predict which patients with S. aureus-bacteremia that will need adjusted dosing via therapeu… Recruiting

2023-505148-20-00 Phase IV 1 country
SMILe: Spinal Morphine or Intravenous Lidocaine in robot-assisted upper urologic surgery Recruiting

2023-505941-21-00 Phase III 1 country
Comparison of albumin and Ringer´s solution for optimization of the plasma volume and hemodynamics during surgery Recruiting

2024-513159-33-00 Phase IV 1 country
Patient-controlled sedation during repair of obstetric perineal lacerations Recruiting

2022-502292-39-00 Phase III 1 country
The Effect of tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy – A randomized pilot… Recruiting

2024-515450-24-00 Phase II 1 country
Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial Recruiting

2024-510921-25-00 Phase II 1 country
Comparing Chlorhexidine and Ethanol ahead of cannulation for haemodialysis - A randomized crossover trial Ended

2023-505935-11-00 Phase IV 1 country

Showing 1–12 of 12 trials

← All sponsors A–Z